Aethlon Medical Inc (AEMD.OQ)
AEMD.OQ on NASDAQ Stock Exchange Capital Market
1.28USD
4:00pm EDT
1.28USD
4:00pm EDT
Change (% chg)
$-0.01 (-0.78%)
$-0.01 (-0.78%)
Prev Close
$1.29
$1.29
Open
$1.29
$1.29
Day's High
$1.29
$1.29
Day's Low
$1.28
$1.28
Volume
3,281
3,281
Avg. Vol
24,405
24,405
52-wk High
$3.85
$3.85
52-wk Low
$0.80
$0.80
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Mar '18 | 0.07 | -0.080 |
| Dec | 0.07 | -0.081 | |
| Sep | 0.00 | -0.144 | |
| Jun | 0.00 | -0.209 | |
| FY 2017 | Mar '17 | 0.00 | -0.217 |
| Dec | 0.00 | -0.152 | |
| Sep | 0.39 | -0.291 | |
| Jun | 0.00 | -0.276 | |
| FY 2016 | Mar '16 | 0.20 | -0.164 |
| Dec | 0.30 | -0.160 | |
| Sep | 0.19 | -0.161 | |
| Jun | 0.19 | -0.176 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 1 | 0.00 | 0.00 | 0.00 | -- |
| Quarter Ending Mar-18 | 1 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Mar-18 | 1 | 0.08 | 0.08 | 0.08 | -- |
| Year Ending Mar-19 | 1 | 0.00 | 0.00 | 0.00 | -- |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 1 | -0.06 | -0.06 | -0.06 | -- |
| Quarter Ending Mar-18 | 1 | -0.10 | -0.10 | -0.10 | -- |
| Year Ending Mar-18 | 1 | -0.48 | -0.48 | -0.48 | -- |
| Year Ending Mar-19 | 1 | -0.28 | -0.28 | -0.28 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 41.26 | 32.86 | |
| P/E High - Last 5 Yrs. | -- | 41.17 | 47.09 | |
| P/E Low - Last 5 Yrs. | -- | 24.91 | 24.92 | |
| Beta | 1.98 | 0.76 | 0.81 | |
| Price to Sales (TTM) | 155.51 | 7.82 | 8.16 | |
| Price to Book (MRQ) | 3.73 | 6.38 | 4.20 | |
| Price to Tangible Book (MRQ) | 3.84 | 15.46 | 6.23 | |
| Price to Cash Flow (TTM) | -- | 28.16 | 22.15 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.85 | 1.73 | |
| Dividend Yield - 5 Year Avg | -- | 1.07 | 1.46 | |
| Dividend 5 Year Growth Rate | -- | 17.79 | -6.24 | |
| Payout Ratio(TTM) | -- | 31.88 | 46.95 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 10.39 | 4.76 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -61.84 | 12.08 | 12.07 | |
| Sales - 5 Yr. Growth Rate | -34.38 | 10.13 | 7.67 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 63.22 | 18.48 | 48.53 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 45.00 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 15.83 | 7.99 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 7.27 | 7.59 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.15 | 2.56 |
| Current Ratio (MRQ) | 15.13 | 2.76 | 3.63 |
| LT Debt to Equity (MRQ) | 13.71 | 24.81 | 13.24 |
| Total Debt to Equity (MRQ) | 13.71 | 31.19 | 17.38 |
| Interest Coverage (TTM) | -13.33 | 25.35 | 35.72 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 58.20 | 55.29 | |
| Gross Margin - 5 Yr. Avg. | -- | 58.06 | 53.23 | |
| EBITD Margin (TTM) | -3,205.09 | -- | -- | |
| EBITD - 5 Yr. Avg | -581.95 | 23.84 | 15.62 | |
| Operating Margin (TTM) | -3,480.84 | 19.18 | -0.76 | |
| Operating Margin - 5 Yr. Avg. | -722.10 | 16.58 | 10.76 | |
| Pre-Tax Margin (TTM) | -3,809.54 | 18.77 | 1.14 | |
| Pre-Tax Margin - 5 Yr. Avg. | -1,006.27 | 16.38 | 10.90 | |
| Net Profit Margin (TTM) | -3,809.54 | 14.50 | -2.16 | |
| Net Profit Margin - 5 Yr. Avg. | -1,006.27 | 11.46 | 7.25 | |
| Effective Tax Rate (TTM) | -- | 12.13 | 20.78 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 27.78 | 24.32 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 24,937 | 27,679,871 | 732,349,814 | |
| Net Income/Employee (TTM) | -949,973 | 3,555,717 | 85,388,927 | |
| Receivable Turnover (TTM) | 4.00 | 4.83 | 5.94 | |
| Inventory Turnover (TTM) | -- | 3.28 | 3.70 | |
| Asset Turnover (TTM) | 0.03 | 0.77 | 0.87 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -125.57 | 10.90 | 10.32 | |
| Return on Assets - 5 Yr. Avg. | -341.02 | 9.56 | 10.99 | |
| Return on Investment (TTM) | -139.52 | 14.50 | 13.13 | |
| Return on Investment - 5 Yr. Avg. | -- | 12.45 | 14.20 | |
| Return on Equity (TTM) | -166.79 | 17.67 | 15.07 | |
| Return on Equity - 5 Yr. Avg. | -- | 15.06 | 15.53 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -61.84 | -41.89 | -34.38 |
| EPS (TTM) % | 50.80 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Aethlon Medical Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 17.85% |
| # of Holders: | 23 |
| Total Shares Held: | 3,169,727 |
| 3 Mo. Net Change: | 0 |
| # New Positions: | 0 |
| # Closed Positions: | 0 |
| # Increased Positions: | 0 |
| # Reduced Positions: | 0 |
| # Net Buyers: | 0 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.